Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04370704
What this trial is testing

Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

Who this might be right for
Melanoma
Incyte Corporation 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Early research (Phase 1)Study completedNCT05236998
What this trial is testing

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
SK Chemicals Co., Ltd. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06494943
What this trial is testing

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Fudan University 27
Early research (Phase 1)Study completedNCT01879371
What this trial is testing

Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate

Who this might be right for
Healthy
Boehringer Ingelheim 36
Testing effectiveness (Phase 2)Study completedNCT03484923
What this trial is testing

Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 196
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Large-scale testing (Phase 3)Study completedNCT02639247
What this trial is testing

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 333
Testing effectiveness (Phase 2)Study completedNCT01968109
What this trial is testing

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Who this might be right for
Neoplasms by Site
Bristol-Myers Squibb 1,482
Large-scale testing (Phase 3)Study completedNCT03631732
What this trial is testing

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

Who this might be right for
HIV-1 Infection
Gilead Sciences 496
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Early research (Phase 1)Study completedNCT02993237
What this trial is testing

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

Who this might be right for
HIV-1
Janssen Research & Development, LLC 27
Early research (Phase 1)Study completedNCT02215122
What this trial is testing

Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs

Who this might be right for
AsthmaCOPD
Mylan Pharma UK Ltd. 40
Large-scale testing (Phase 3)Study completedNCT03405935
What this trial is testing

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

Who this might be right for
HIV-1 Infection
Gilead Sciences 86
Large-scale testing (Phase 3)Study completedNCT03682848
What this trial is testing

Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Who this might be right for
HIV Infections
ViiV Healthcare 32
Not applicableStudy completedNCT01316419
What this trial is testing

Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 2,089
Large-scale testing (Phase 3)Study completedNCT03403712
What this trial is testing

Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 404
Testing effectiveness (Phase 2)Study completedNCT04817800
What this trial is testing

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

Who this might be right for
Seasonal Allergic Rhinitis
Humanis Saglık Anonim Sirketi 48
Early research (Phase 1)Study completedNCT01518712
What this trial is testing

Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Early research (Phase 1)Study completedNCT00349934
What this trial is testing

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

Who this might be right for
Metastatic Breast Cancer
Immutep S.A.S. 33
Next Page